Premium
Extra‐amniotic prostaglandin‐E 2 for termination in the second and early third trimesters
Author(s) -
Rouzi A.A.,
Hawasawi H.,
Abduljabbar H.
Publication year - 1999
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(99)00090-9
Subject(s) - obstetrics and gynaecology , medicine , university hospital , general hospital , gynecology , obstetrics , library science , family medicine , pregnancy , genetics , computer science , biology
Termination of pregnancy in the second and early third trimesters has always been a common challenge in obstetrical practice. In the United States dilation and evacuation in the second w x trimester is preferred 1 , while in the United w x Kingdom prostaglandin analogues are favored 2 . Between November 1995 and June 1998, 43 consecutive pregnant women underwent termination of pathological pregnancy in second and early third trimesters according to a protocol using Ž . extra-amniotic prostaglandin-E EAPGE in the 2 2 Department of Obstetrics and Gynecology at King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia. The protocol was approved by the institution review board. Consent was obtained from all women. Ultrasonography was used routinely to confirm the gestational age. On the day of termination, a 16-French Foley’s catheter with a 30-ml balloon was positioned in the internal cervical os